Genmab | GEN - Pre Tax Profit

Stock Price
1,958.00
Daily Change
-29.50 -1.48%
Monthly
-9.60%
Yearly
41.37%
Q1 Forecast
1,920.90

Genmab reported DKK482M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Agios Pharmaceuticals USD -103.43M 8.59M Sep/2025
Amarin USD -8.12M 5.34M Sep/2025
Amgen USD 3.92B 2.35B Sep/2025
argenx SE USD 386.05M 99.15M Sep/2025
AstraZeneca USD 3.24B 117M Sep/2025
Bayer EUR -1.16B 735M Sep/2025
BioMarin Pharmaceutical USD -26.32M 324.19M Sep/2025
Demant DKK 1.46B 497M Jun/2025
Exelixis USD 252.41M 22M Sep/2025
Fresenius Medical Care EUR 402.57M 52.02M Sep/2025
Galapagos EUR -221.49M 117.07M Sep/2025
Genmab DKK 482M 59M Sep/2025
GlaxoSmithKline GBP 1.23B 1.23B Dec/2025
GN Store Nord DKK 450M 332M Dec/2025
GRIFOLS EUR 190.51M 20.03M Jun/2025
Hikma Pharmaceutical USD 147.5M 3.5M Jun/2025
Insmed USD -368.7M 48.26M Sep/2025
Lonza CHF 624M 197M Dec/2024
Merck EUR 1.29B 458.1M Sep/2025
Novartis USD 4.2B 335M Sep/2025
Regeneron Pharmaceuticals USD 1.76B 244.6M Sep/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sanofi EUR -1.16B 5.5B Dec/2025
UCB EUR 789M 427M Jun/2025